Back to Search Start Over

Contrasting Fake News in Oncology: The First Declaration of Good Communication.

Authors :
Berardi R
Papa R
Scandali VM
Torniai M
Blasi M
Brusa A
Elisei F
Gregori GL
Laurenzi G
Marinelli L
Marinelli M
Mazzoli G
Volpini F
Caporossi M
Source :
JCO global oncology [JCO Glob Oncol] 2021 May; Vol. 7, pp. 740-746.
Publication Year :
2021

Abstract

Purpose: Nowadays, websites, online journals, and social media give access to an extraordinary amount of medical information. Misleading news are often disseminated generating false expectations, exaggerated anxiety, and confusion; in oncology setting, disinformation is perhaps more deleterious than in other fields, with a considerable impact on single patients as well as on families and, more in general, on Public Health. We aimed to promote a better interaction between the health care and the world of communication.<br />Materials and Methods: A regional technical table was established with the aim of drafting a shared document through the consensus conference method in the RAND/University of California Los Angeles variant, identifying strategies to overcome barriers between communication and health care as well as to propose common criteria for an effective dissemination of medical information.<br />Results: Sixteen articles met the inclusion criteria, from which 72 recommendations were drawn to the communication and health field (40 related to specific issues and 32 transversal to all the specific topics). Following an evaluation of relevance by the panel of experts, it was found that 57 recommendations scored more than 7, 13 between 4 and 6.9, and 2 below 4.<br />Conclusion: This consensus and the drawn up document represent a concrete attempt to find a renewed and strategic alliance between key figures in health care and communication operators. As the American Declaration of Independence, our Declaration of Good Communication has identified high-impact recommendations for the best management of patients, providing simple but fundamental concepts and recommendations about effectiveness especially in oncology setting.<br />Competing Interests: Rossana BerardiConsulting or Advisory Role: Lilly, Boehringer Ingelheim, Amgen, AstraZeneca, Novartis, Roche, GlaxoSmithKline, Eisai, MSD Oncology Massimiliano MarinelliHonoraria: Apoteca FarmacieNo other potential conflicts of interest were reported.

Details

Language :
English
ISSN :
2687-8941
Volume :
7
Database :
MEDLINE
Journal :
JCO global oncology
Publication Type :
Academic Journal
Accession number :
34019461
Full Text :
https://doi.org/10.1200/GO.21.00003